Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$4.27 – $10.65
43% from low
Exchange
OTC Link
OS
Borrow rate
0.87%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2M | $4.0M | $2.1M | $1.5M | $2.3M | $2.3M | $17.8M | $17.0M |
| Cost of revenue | $1.2M | $3.4M | $2.2M | $1.7M | $1.7M | $1.5M | $11.8M | $15.0M |
| Gross profit | $1.9M | $587.5K | −$70.1K | −$240.9K | $561.0K | $892.3K | $6.0M | $8.6M |
| Gross margin | 61.3% | 14.7% | -3.3% | -16.3% | 24.3% | 38.0% | 33.6% | 50.3% |
| R&D | $1.1M | $1.2M | $1.5M | $610.3K | $778.5K | $1.4M | $1.3M | $2.0M |
| Operating income | −$3.2M | −$3.2M | −$4.1M | −$2.3M | −$2.9M | −$4.3M | −$858.4K | −$1.0M |
| EBITDA | −$2.3M | −$1.0M | −$2.6M | −$1.6M | −$1.6M | −$3.7M | −$172.0K | −$5.1M |
| Net income | −$3.2M | −$2.7M | −$4.4M | −$3.3M | −$3.4M | −$4.6M | −$1.2M | −$4.3M |
| Net margin | -100.6% | -67.2% | -204.1% | -226.9% | -149.6% | -196.1% | -6.9% | -25.5% |
| EPS (diluted) | -3.04 | -2.65 | -3.62 | -2.26 | -1.74 | -2.03 | -0.50 | -1.76 |
Annual figures · source: Financial Modeling Prep
DEVONIAN HLTH GROUP INC
No one on the platform currently holds DVHGF.
No tracked institution reports a position in DVHGF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-01-22 | 1-for-60reverse |
No one on the platform has traded DVHGF yet.
| $28M |
| — |
| INTIInhibitor Therapeutics, Inc. | $0.09 | +0.00% | $16M | — |
| LVCLFAlgorae Pharmaceuticals Limited | $0.01 | +17.90% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.6× sales vs its 6.0× historical median P/S.
Fair value ≈ $70.69 · price $7.00 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$DVHGF Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine™ in Wound Healing https://www.stocktitan.net/news/DVHGF/devonian-files-patent-cooperation-treaty-pct-application-for-1ujwksgx2as7.html
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on June 20, 08:45:00: Groupe Santé Devonian reçoit un avis d'autorisation de délivrance d https://s.flashalert.me/nZg5v
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on June 20, 08:45:00: Devonian Health Group Receives a Notice of Allowance for Issuance of a U https://s.flashalert.me/ZN1H5F
View on StockTwits ↗$DVHGF Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease. https://www.stocktitan.net/news/DVHGF/devonian-health-group-receives-a-notice-of-allowance-for-issuance-of-4mgluw2o9vxz.html #patent
View on StockTwits ↗$DVHGF Devonian Announces Closing of a Private Placement of $1.2 Million https://www.stocktitan.net/news/DVHGF/devonian-announces-closing-of-a-private-placement-of-1-2-g86opahtf7n7.html
View on StockTwits ↗$DVHGF Devonian Announces Private Placement of up to $5 Million https://www.stocktitan.net/news/DVHGF/devonian-announces-private-placement-of-up-to-5-usab7uqocchb.html
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on May 16, 08:45:00: Groupe Santé Devonian annonce la présentation des résultats d’efficacité https://s.flashalert.me/gE3ko
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on May 16, 08:45:00: Devonian Health Group Announces Presentation of Thykamine™ Efficacy Resul https://s.flashalert.me/66ol3
View on StockTwits ↗$DVHGF Devonian Health Group Announces Presentation of Thykamine™ Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine™ Clinical Development Program Update. https://www.stocktitan.net/news/DVHGF/devonian-health-group-announces-presentation-of-thykamine-efficacy-id3fh3hf2p2a.html
View on StockTwits ↗$DVHGF Devonian Announces Filing of Preliminary Base Shelf Prospectus https://www.stocktitan.net/news/DVHGF/devonian-announces-filing-of-preliminary-base-shelf-m8sc3l4ggk3w.html
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on March 30, 16:00:00: Devonian annonce l’approbation de modifications à son régime d’options https://s.flashalert.me/02Fkn
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on March 30, 16:00:00: Devonian Announces Approval of Amendments to its Stock Option Plan and https://s.flashalert.me/5K9eD9
View on StockTwits ↗$DVHGF Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan https://www.stocktitan.net/news/DVHGF/devonian-announces-approval-of-amendments-to-its-stock-option-plan-oct68943whqj.html
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on March 24, 16:00:00: Groupe Santé Devonian annonce les résultats de l’Assemblée Générale Ann https://s.flashalert.me/R78fB
View on StockTwits ↗$DVHGF [15s. delayed]: Issued Press Release on March 24, 16:00:00: Devonian Health Group Announces voting results of the Annual General an https://s.flashalert.me/maimqI
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.